In addition to local sequence elements the regulation of the high-level, development-and tissue-specific expression of the human # globin gene cluster appears to require distant regulatory sequences which have been termed locus control region. In the chromatin of erythroid cells the locus control region is characterized by four DNaseI hypersensitive sites that are located 6-18 kb 5' of the E globin gene. The definition of the sequences minimally required for locus control region activity is likely to further the understanding of its physiology and will be of interest for the development of somatic gene therapy strategies of the hemoglobinopathies.
Introduction
Some of the sequence elements involved in the regulation of globin gene expression are situated in close proximity to the transcription start sites. Recombinant globin genes with minimal flanking sequences have thus been shown to be expressed inducibly in transfected erythroid cell lines (1) (2) (3) (4) and tissue and development specifically in transgenic mice (5) (6) (7) (8) (9) . Also, retrovirally transfected bone marrow cells exhibited erythroid specific expression of the exogenous ,3 globin gene (10) . However, the level of globin gene expression in those experiments was position dependent and generally low. It appeared therefore that additional regulatory elements are required to confer physiologic levels of globin gene expression.
The DNA flanking the lB globin gene cluster contains sequences that are arranged in the chromatin oferythroid cells to be particularly sensitive to DNaseI degradation which presumably reflects their availability to regulatory trans acting factors (1 1). These DNaseI hypersensitive sequences were shown to confer high level and position independent expression of a ft globin gene in transgenic mice and in transfected cell lines (12) . This area has therefore been termed dominant control region (DCR)1 (12) , locus activating region (LAR) (13) , or locus control region (LCR) according to an agreement on the nomenclature reached at the 1990 Hemoglobin Switching Conference.
The ft globin LCR contains four erythroid-specific DNaseI hypersensitive sites (termed HS 1-4) which are located in an area 6-18 kb 5' of the e globin gene ( Figs. 1 and 2 ). The minimal requirements for the # globin LCR to confer position independent, high-level, and erythroid-specific expression of recombinant globin or heterologous genes has been studied in enhancer trap assays (14) , in transgenic mice (12, 15, 16) , and in transfected cell lines (17) (18) (19) (20) . Although all these experiments suggest a particularly important role of HS 2 the respective influence of the other hypersensitive sites on regulated globin gene expression is controversial. The enhancer trap and the transgenic mice assays indicate that HS 2 alone is both necessary and sufficient for conferring high-level, erythroid-specific globin gene expression. The minimal sequence requirement for this effect appears to be contained in a core of 300 (19) or even 46 bp (20) . However, f# globin genes linked to the complete LCR are more active in transgenic mice than those coupled to HS 2 only (21). The evidence obtained from transfected Friend cells also points to a more complex interaction of at least three of the four sites (22) .
In vivo, the importance of the LCR for regulated globin gene expression is less well documented (Fig. 1) . Two deletions encompassing much of the (B globin gene cluster including the LCR but not the # globin gene itself(23-25) result in a thalassemic phenotype. However, these deletions are -100 kb large (26) and may therefore inactivate the structurally normal ft globin gene by other mechanisms than deletion of the LCR. Another deletion associated with a thalassemic phenotype removes -30 kb including the three most distal LCR elements (HS 2-4) and sequences upstream indicating that HS 1 alone is not sufficient for LCR activity (27) .
In the family presented here, a 3,030-bp deletion of the most 3' LCR element (HS 1) is demonstrated to be linked to a 1. Abbreviations used in this paper: DCR, dominant control region; HS, DNaseI hypersensitive site; LAR, locus activating region; LCR, locus control region; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism. 
Methods
Hematological analyses. These were performed using standard methods. HbA2 was measured chromatographically (28) and HbF by alkali denaturation (29) . Restriction mapping. Restriction digests were performed with the various enzymes according to the manufacturer's recommendations (Pharmacia Fine Chemicals, Uppsala, Sweden). Southern blotting was done using standard methods (30) . The filters were hybridized with 32P-labeled genomic fragment probes. The 5' probe (pI in Figs. 2 and 3) was a Bgl II/Hind III fragment isolated from the recombinant 5EIII (31) . The 3' probe (p2 in Figs. 2 and 3) was a Bam HI/Eco RI fragment containing the genomic e globin gene (32) . The C-OT mutation at position-158 ofthe 07 globin gene was detected by Southern blot analysis of Xmn I digested genomic DNA hybridized to a y globin gene probe.
The haplotype ofDNA polymorphisms within the # globin gene cluster (ft haplotype) was determined according to Orkin et al. (32) .
Allele-specific oligonucleotide hybridization. The mutation ofthe , globin gene was determined after PCR amplification (30) ofthe 5' portion of the (3 globin gene using 24mer oligonucleotides (5'-TATGCTTACCAAGCTGTGATTCCA; 5'-AGGGGAAAGAAA-ACATCAAGGGTC) as primers. The amplification products were dotted and UV cross-linked on nylon membranes and hybridized (33) to 32P-endlabeled 20 mer oligonucleotides (5'-CTCCTGAGGAGAAGT-TCTGC; 5'-CTCCTGAGGGAAGTTCTGCC) spanning codon 6 and representing the normal or the GAG--G-G mutated sequence.
DNA sequencing. The deletion breakpoint was PCR amplified with primers (5'-AACACCTCTAGGCTATAAGGCAAC; 5'-ATAAGG-ACCAGGTATCTCAAGGCC) whose homologous sequences were known by gene mapping studies to be preserved by the deletion (Fig. 2) . The amplified fragment was inserted into a pSP64 vector and sequenced by the dideoxy-nucleotide chain termination technique using sequencing primers from both sides of the polylinker (30) .
Results
Hematological analyses. The two Italian index patients presented with the clinical and hematological picture of homozygous (3 thalassemia intermedia. The considerable production of HbF is the likely reason for their relatively mild phenotype.
The parents showed the typical features ofheterozygous # thalassemia minor without a hereditary persistence of fetal hemoglobin synthesis (Fig. 4) .
Identification ofthe A thalassemia mutation. The patients and their parents were shown by allele-specific oligonucleotide hybridization of PCR amplified (3 globin gene fragments to be homozygous and heterozygous, respectively, for the codon 6 frameshift GAG-*.G-G (30thalassemia mutation (not shown). Restriction mapping. (3haplotype analysis showed linkage of the (3 thalassemia mutation to haplotype IX according to Orkin et al. (32) . The parents' normal # globin genes were linked to haplotype I (Fig. 4) . These two haplotypes differ at multiple sites including the Hind II RFLP 5' of the e globin gene. Xmn I mapping indicated the linkage of the ( thalassemia mutation with the C-U-T mutation at position-1 58 of the G globin gene promoter (not shown). This mutation has previously been associated with raised HbF levels and a mild clinical phenotype ofhomozygous # thalassemia (34) (35) (36) (1 1), and multiple recognition sites for the erythroid-specific DNA binding protein GF-I (37). GAG-G--G) and for a promoter mutation of the 0y globin gene (C-UT at position-158) and presented with the clinical and hematologic picture of thalassemia intermedia. These mutations were linked to a haplotype of restriction polymorphisms in the P globin gene cluster termed #IX according Orkin et al. (32) . Both parents were healthy and showed the typical hematologic picture of heterozygous j# thalassemia. Their normal P globin genes were linked to the P haplotype #1 and, in the case of the father, to the 3,030-bp deletion of HS 1 (stippled).
The definition of the minimal requirements for the activity of the #t globin LCR is likely to contribute to the understanding of the complex mechanisms involved in globin gene regulation.
The studies in transfected cell lines and in transgenic mice suggest that the chiefLCR effect depends on short DNA sequences within HS 2 or HS 3 (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . However, the interpretation of the experimental results is complicated by a number of variables which are difficult to be controlled for. Developing transgenic mice with a very high expression of exogenous globin genes may thus become thalassemic and will probably be selected against. Also, studies oftransfected cell lines are unlikely to reflect all relevant levels of gene regulation. It is important therefore to corroborate the conclusions drawn from the experimental approach by the observation ofnaturally occurring mutants. An analysis of the three larger LCR deletions (Fig. 1) supports the idea that HS 2-4 are necessary and that HS 1 is not sufficient for LCR activity (24, 25, 27 
